MedAnnex, a company which is working with a team at UCL headed by Professor David Isenberg and Professor Claudia Mauri (both UCL Division of Medicine), has secured £11m in funding to develop antibodies designed to treat autoimmune disorders and other serious diseases.
Read: Scotsman
Close
